Grabar Law Office Investigates Claims on Behalf of Shareholders of Applied Therapeutics, Inc. (APLT) As Securities Fraud Class Action Reaches Settlement

Philadelphia, Pennsylvania--(Newsfile Corp. - September 9, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/applied-therapeutics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.

WHY? As alleged in a recently filed securities fraud class action complaint, Applied Therapeutics, Inc. (NASDAQ: APLT), through certain of its officers, provided positive statements to investors while, at the same time, disseminating false and materially misleading statements and/or concealing material adverse facts concerning the true state of Applied Therapeutics' Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study. The Complaint further alleges that such statements absent these material facts caused Plaintiff and other shareholders to purchase Applied Therapeutics' securities at artificially inflated prices.

On August 25, 2025, the parties reported to the Court that they had agreed to settle the securities fraud class action.

WHAT YOU CAN DO NOW: If you purchased Applied Therapeutics (NASDAQ: APLT) shares prior to January 3, 2024, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/applied-therapeutics-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.

$APLT #AppliedTherapeutics

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265795